Clinical Efficacy of a 2-Week Treatment Course of Zuranolone for the Treatment of Major Depressive Disorder and Postpartum Depression: Outcomes From the Clinical Development Program

INTRODUCTION: Antidepressants that offer a rapid onset of action without requiring chronic use are greatly needed in both major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational, oral, neuroactive steroid and GABA(A) receptor positive allosteric modulator in...

Descripción completa

Detalles Bibliográficos
Autores principales: Clayton, A., Cutler, A.J., Deligiannidis, K.M., Lasser, R., Sankoh, A.J., Doherty, J., Kotecha, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567193/
http://dx.doi.org/10.1192/j.eurpsy.2022.282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567193/
http://dx.doi.org/10.1192/j.eurpsy.2022.282

Ejemplares similares